Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 |
| 15 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $269K 33.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 23.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Tanious Jubran N.President & COO | Grant or award | A | $1.20M 153.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Vincent George H.Executive Vice President | Grant or award | A | — 850 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Nichols Brian WGroup VP & Controller | Grant or award | A | — 921 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Fuchsen Matthew RChief Development Officer | Grant or award | A | — 2,345 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Parrish DeanEVP & Chief Operating Officer | Grant or award | A | — 4,795 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Hill Jesse P.Chief Financial Officer | Tax withholding | F | $2,254 394 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | — 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Gill AnnSVP, Chief Accounting Officer | Grant or award | A | — 1,359 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | — 773 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Le Pendeven YvesCFO | Option exercise | M | — 9,767 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Cerwin Brittany CChief Accounting Officer | Grant or award | A | — 1,807 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Bothwick Jay EDirector | Option exercise | M | — 625 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Shaffer Megan N.Group Vice President | Grant or award | A | — 3,002 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Kennerley David John ChristopherExecutive Vice President & CFO | Grant or award | A | — 3,177 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Moore Kathryn ASVP, HUMAN RESOURCES | Tax withholding | F | $42K 88 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Kelley Joseph MichaelSenior Vice President | Grant or award | A | — 2,941 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | O'Brien JennieSVP, Chief Accounting Officer | Grant or award | A | — 9,917 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Gilligan SarahChief Sup Chn & Transform Ofcr | Tax withholding | F | $29K 1,233 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Reed Timothy R.EVP, R&D and Tour | Option exercise | M | — 11.4K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Doucet Terrence Gregory JosephSee Remarks | Option exercise | M | — 23.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Doucet Terrence Gregory JosephSee Remarks | Tax withholding | F | $43K 12.2K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Thiele Candace LEVP, Chief Administrative Offi | Option exercise | M | — 398 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Watson Michael JamesEVP, Head of Axos Securities | Option exercise | M | — 1,349 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Watson Michael JamesEVP, Head of Axos Securities | Option exercise | M | — 1,105 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | O'Malley KathrynChief Credit Officer | Grant or award | A | — 692 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Perros EvangelosChief Financial Officer | Option exercise | M | — 20.6K sh | Mar 16, 2026 traded Mar 12, 2026 |